Last Updated: September 29, 2026

TROMETHAMINE - Generic Drug Details

Name: TROMETHAMINE Generic Launch, Drug Patent, and Exclusivity Dataset
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

✉ Email this page to a colleague

« Back to Dashboard

What are the generic sources for tromethamine and what is the scope of patent protection?

Tromethamine is the generic ingredient in two branded drugs marketed by Hospira, B Braun Medical, and Milla Pharms, and is included in three NDAs. Additional information is available in the individual branded drug profile pages.

Three suppliers are listed for this compound.

Summary for TROMETHAMINE

US Patents:	0
Tradenames:	2
Applicants:	3
NDAs:	3
Finished Product Suppliers / Packagers:	3
Raw Ingredient (Bulk) Api Vendors:	300
Clinical Trials:	92
Patent Applications:	7,150
What excipients (inactive ingredients) are in TROMETHAMINE?	TROMETHAMINE excipients list
DailyMed Link:	TROMETHAMINE at DailyMed

Recent Clinical Trials for TROMETHAMINE

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
SYED HAIDER ALI	NA
Al-Azhar University	EARLY_PHASE1
Tanta University	PHASE1

See all TROMETHAMINE clinical trials

Medical Subject Heading (MeSH) Categories for TROMETHAMINE

Buffers
Excipients

US Patents and Regulatory Information for TROMETHAMINE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
B Braun Medical	TROMETHAMINE	tromethamine	SOLUTION;INJECTION	211558-001	Dec 9, 2024	AP	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Hospira	THAM	tromethamine	SOLUTION;INJECTION	013025-002	Approved Prior to Jan 1, 1982	AP	RX	Yes	Yes	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Milla Pharms	TROMETHAMINE	tromethamine	SOLUTION;INJECTION	213116-001	Dec 31, 2024	AP	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.